Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Handling and Processing Plasma

Posted on By

Protocol for Plasma Handling and Processing in BA/BE Studies

Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the proper handling, processing, and storage of plasma samples collected from study participants in Bioavailability (BA) and Bioequivalence (BE) studies conducted in the pharmaceutical industry.

Scope

This SOP applies to all personnel involved in the receipt, processing, and storage of plasma samples, including Clinical Research Associates (CRAs), Laboratory Technicians, and Data Managers.

Responsibilities

  • The Study Coordinator is responsible for coordinating plasma sample collection activities and ensuring compliance with the study protocol and regulatory requirements.
  • The Laboratory Technician or designated personnel are responsible for processing plasma samples according to established procedures and safety guidelines.
  • The Data Manager is responsible for maintaining accurate records of plasma sample receipt, processing, and storage, and ensuring data integrity throughout the process.
See also  SOP for Auditing Clinical and Bioanalytical Facilities

Procedure

  1. Receive plasma samples from the study site or designated collection site, ensuring proper packaging, labeling, and documentation.
  2. Inspect plasma samples upon receipt for any signs of damage, leakage, or contamination, and record any discrepancies or deviations.
  3. Centrifuge plasma samples immediately after receipt to separate plasma from cells or other components, following established centrifugation protocols.
  4. Aliquot plasma samples into labeled tubes or containers using sterile techniques and appropriate pipetting equipment.
  5. Record sample aliquoting details, including
volume, date, and time of aliquoting, and any relevant identifiers or annotations.
  • Store aliquoted plasma samples at the appropriate temperature and conditions specified in the study protocol or standard operating procedures.
  • Maintain accurate and up-to-date inventory records of plasma samples, including location, quantity, and expiration dates.
  • Dispose of unused or expired plasma samples according to established protocols and regulatory requirements.
  • Abbreviations

    • SOP – Standard Operating Procedure
    • BA – Bioavailability
    • BE – Bioequivalence
    • CRA – Clinical Research Associate

    Documents

    • Plasma Sample Receipt Log
    • Plasma Processing Records
    • Plasma Sample Inventory
    • Disposal Documentation

    Reference

    International Conference on Harmonisation (ICH) E6 Good Clinical Practice guidelines and relevant regulatory requirements for sample handling and processing.

    SOP Version

    Version 1.0

    See also  SOP for Handling Exclusion and Inclusion Criteria
    Bioequivalence Bioavailability Study Tags:AUC (area under the curve), BE assessment, Bioavailability study, Bioequivalence study, clinical trials, Cmax (maximum concentration), Comparative pharmacokinetics, Drug absorption, Drug absorption rate, Drug bioanalysis, Drug development, Drug dissolution, Drug formulation, Drug metabolism, In vitro bioequivalence, In vivo bioavailability, Pharmacokinetic parameters, Pharmacokinetics, SOP for Bioavailability study, SOP for Bioequivalence study, Therapeutic equivalence, Tmax (time to maximum concentration)

    Post navigation

    Previous Post: SOP for Blood Sample Collection
    Next Post: SOP for Bioanalytical Method Validation

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version